News

Featured News

  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • News | September 17, 2021

    Skyhawk Therapeutics Completes New Investment Round

    Read More

    News | September 17, 2021

    DICE Therapeutics Announces Pricing of Upsized Initial Public Offering

    Read More

    News | September 17, 2021

    ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021

    Read More

    Press Release | August 18, 2021

    Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases

    Read More

    News | July 13, 2021

    ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells

    Read More

    News | June 1, 2021

    Alloy Therapeutics and Pyxis Oncology Form Kyma Therapeutics to Develop Novel Immune-Modulating Antibodies for Cancer and Autoimmune Diseases

    Read More

    News | May 18, 2021

    Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform

    Read More

    Press Release | March 31, 2021

    Entrada Therapeutics Announces Closing of $116 Million Series B Financing

    Read More

    Press Release | March 30, 2021

    Pyxis Oncology Closes $152 Million Series B Financing to Further Advance Portfolio of Biologics

    Read More

    Press Release | March 18, 2021

    Pyxis Oncology Announces Worldwide Licensing Agreement with Pfizer to Develop and Commercialize Multiple Antibody-Drug Conjugates

    Read More

    News | March 18, 2021

    CAR-M era begins as Carisma doses first patient

    Read More

    News | January 8, 2021

    DiCE gets its ‘library’ card ready as it speeds development of DNA database-derived molecules with more investor cash

    Read More

    News | January 7, 2021

    CARISMA Therapeutics Completes Series B Funding to Advance Development of Novel CAR-Macrophage Immunotherapies

    Read More

    Press Release | December 21, 2020

    Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)

    Read More

    News | November 20, 2020

    Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal

    Read More

    Press Release | November 5, 2020

    Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting

    Read More

    News | November 3, 2020

    Orbus Therapeutics Publishes in Oncotarget Scientific Journal

    Read More

    Press Release | October 22, 2020

    Orbus Therapeutics Expands Series A Financing to $71 Million to Support Ongoing STELLAR Phase 3 Study in Rare Brain Cancer

    Read More

    Press Release | October 19, 2020

    Aptinyx Reports Positive, Statistically Significant, Top-line Data From Phase 2 Study of NYX-783 in Patients With Post-Traumatic Stress Disorder

    Read More

    Press Release | October 15, 2020

    Precision BioSciences Announces U.S. Patent Trial and Appeal Board Upholds Allogeneic CAR T Patents

    Read More